BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Bioinformatics Software | QIAGEN Digital Insights - ECPv6.15.20//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://staging.digitalinsights.supremeclients.com
X-WR-CALDESC:Events for Bioinformatics Software | QIAGEN Digital Insights
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:UTC
BEGIN:STANDARD
TZOFFSETFROM:+0000
TZOFFSETTO:+0000
TZNAME:UTC
DTSTART:20220101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=UTC:20230504T110000
DTEND;TZID=UTC:20230504T120000
DTSTAMP:20260504T030418
CREATED:20230329T123527Z
LAST-MODIFIED:20241024T182853Z
UID:10000628-1683198000-1683201600@staging.digitalinsights.supremeclients.com
SUMMARY:Como anotar variantes somáticas e avaliar a prevalência delas com um único banco de dados
DESCRIPTION:Dentro das aplicações oncológicas\, a habilidade de identificar alterações genéticas potencialmente acionáveis e explorar as vulnerabilidades moleculares do câncer está se tornando cada vez mais difícil. \nUm novo banco de dados desenvolvido pela QIAGEN\, o HSMD\, contém mais de 2 décadas de conteúdo com curadoria especializada e dados da QIAGEN Knowledge Base com mais de 300.000 casos oncológicos de mundo real para fornecer um entendimento profundo e preciso da acionabilidade de variantes pequenas\, tais como SNVs\, indels e frameshifts\, que têm sido “observadas clinicamente” ou consideradas pela literatura científica. \nNo dia 4 de maio\, junte-se a nossos especialistas para um tour virtual do novo banco de dados e apresentação dos seus recursos\, capacidades e aplicações.
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/como-anotar-variantes-somaticas-e-avaliar-a-prevalencia-delas-com-um-unico-banco-de-dados/
LOCATION:Virtual - Portugal\, Portugal
CATEGORIES:Clinical,Webinar
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20230504T130000
DTEND;TZID=UTC:20230504T143000
DTSTAMP:20260504T030418
CREATED:20230418T122646Z
LAST-MODIFIED:20241024T182855Z
UID:10000631-1683205200-1683210600@staging.digitalinsights.supremeclients.com
SUMMARY:Single-cell RNA-seq data analysis and interpretation
DESCRIPTION:Explore how to analyze and interpret your own single-cell RNA-seq (scRNA-seq) data using QIAGEN CLC Genomics Workbench and QIAGEN Ingenuity Pathway Analysis (IPA). \nIn this 90-minute training\, you’ll learn how to:\n• Start with FASTQ\, cell matrix file and/or differential expression file for scRNA-seq data\n• Either automate or customize your analysis pipeline/workflow\, depending on your needs\n• Easily generate visualizations such as t-SNE\, UMAP\, heatmap\, differential expression table\, dot plots and more\n• Upload differential expression data to QIAGEN IPA (either from QIAGEN CLC or from another source)\n• Perform pathway analysis on scRNA-seq data and compare different clusters to discover novel biological mechanisms\, cell type-specific biomarkers and key regulators/targets\n• Export results in the form of high-quality images or tabular format \nSlides from a previous similar training: https://qiagen.showpad.com/share/WAXz1vrHBsvArdeceWpcX
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/single-cell-rna-seq-data-analysis-and-interpretation/
LOCATION:Virtual - Americas - EST\, United States
CATEGORIES:Discovery,Training
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20230509T130000
DTEND;TZID=UTC:20230509T143000
DTSTAMP:20260504T030418
CREATED:20230411T170801Z
LAST-MODIFIED:20241024T182854Z
UID:10000629-1683637200-1683642600@staging.digitalinsights.supremeclients.com
SUMMARY:Whole genome sequencing (WGS)\, rapid WGS and ultra-rapid WGS for hereditary disorders – where speed matters
DESCRIPTION:QIAGEN CLC LightSpeed Module delivers an ultra-fast\, end-to-end hereditary NGS FASTQ to VCF pipeline. LightSpeed takes raw FASTQ files generated by paired-end 150 bp sequencing protocols and performs quality trimming\, adapter trimming\, read mapping\, deduplication\, local realignment\, QC and germline variant calling. \nMore details: https://qiagen.showpad.com/share/Tue4ZxKsjAFetyoswbTfE \nCloud module: QIAGEN CLC Genomics Cloud computing software allows you to launch analyses from CLC Workbenches or CLC Servers for execution on AWS.\nhttps://qiagen.showpad.com/share/ct2e3M9LfLazzuMMchqhG\n• Overview of Genomics workbench and Platform\n• Server / Cloud module overview\n• Breaking the speed of light\n• LightSpeed is arguably the fastest and cheapest-to-run hereditary FASTQ-to-VCF WGS pipeline available\n• Benchmarks / comparisons\n• Demo of lightspeed and cloud module for Fastq to vcf\n• Install plugin\n• Download reference(s)\n• Execute workflow and review results
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/whole-genome-sequencing-wgs-rapid-wgs-and-ultra-rapid-wgs-for-hereditary-disorders-where-speed-matters-2/
LOCATION:Virtual - Americas - EST\, United States
CATEGORIES:Discovery,Webinar
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20230511T130000
DTEND;TZID=UTC:20230511T143000
DTSTAMP:20260504T030418
CREATED:20230418T123154Z
LAST-MODIFIED:20241024T182855Z
UID:10000632-1683810000-1683815400@staging.digitalinsights.supremeclients.com
SUMMARY:Checkpoint inhibitors in the context of biomarkers\, drug targets and pathways
DESCRIPTION:In this training\, we will focus on how you can use QIAGEN Omicsoft Studio and QIAGEN Ingenuity Pathway Analysis (IPA) to discover new biomarkers\, validate (or study) drug targets and identify novel mechanisms of action with your own and/or public checkpoint inhibitor datasets from resources like GEO\, SRA\, TCGA and more. \nIn this training\, you’ll learn how to: \n· Investigate the expression of a gene/biomarker/drug target across different treatments and diseases \n· Derive a biomarker/gene signature from a specific condition (for example\, non-responders of a drug\, or a particular disease/disease subtype and others) \n· Correlate expression of multiple genes and biomarkers \n· Compare different experimental groups (e.g.\, your own data and/or public data) at both the levels of gene expression and pathways/regulatory networks activity
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/checkpoint-inhibitors-in-the-context-of-biomarkers-drug-targets-and-pathways/
LOCATION:Virtual - Americas - EST\, United States
CATEGORIES:Discovery,Webinar
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20230516T100000
DTEND;TZID=UTC:20230516T113000
DTSTAMP:20260504T030418
CREATED:20230418T123846Z
LAST-MODIFIED:20241024T182856Z
UID:10000633-1684231200-1684236600@staging.digitalinsights.supremeclients.com
SUMMARY:How to improve your existing pipeline for somatic mutation analysis\, interpretation and reporting: Part 2
DESCRIPTION:We are excited to bring thought leaders\, NGS experts\, lab directors\, variant scientists\, clinicians\, and oncologists under one virtual roof at our second annual Clinical Oncology Summit hosted on April 27 and May 18\, 2023. \nThe two-part\, content-rich event will feature invited lectures from lab directors and clinical geneticists\, thought-provoking discussions on the future of comprehensive genomic profiling\, and educational presentations on the latest databases\, software\, and services for somatic secondary and tertiary analysis. Designed to help clinical diagnostic labs understand how they can optimize their current pipelines for somatic NGS analysis\, interpretation and reporting\, the Clinical Oncology Summit is a must-attend event for labs who need to reduce turnaround time\, improve operational costs\, and scale for higher throughput. \nMeet the speakers and view the full agenda here.
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/how-to-improve-your-existing-pipeline-for-somatic-mutation-analysis-interpretation-and-reporting-part-2-2/
LOCATION:Virtual - EMEA - CET
CATEGORIES:Clinical,Webinar
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20230516T130000
DTEND;TZID=UTC:20230516T143000
DTSTAMP:20260504T030418
CREATED:20230418T124321Z
LAST-MODIFIED:20241024T182856Z
UID:10000634-1684242000-1684247400@staging.digitalinsights.supremeclients.com
SUMMARY:Pathway and network analysis on different types of lists with QIAGEN IPA
DESCRIPTION:You may not have a typical transcriptomics dataset (i.e.\, a list of genes with differential expression)\, yet\, you’d like to analyze a list of IDs. In this training\, we will explore how to perform pathway and network analysis for lists of IDs in QIAGEN IPA.\nExamples of lists that we’ll explore include:\n• A gene/protein/metabolite list coming from a paper\, generated in a lab or from a collaborator without differential expression\n• A list of RS IDs for variants with or without numerical values such as p-values\n• A list of proteins with Z-score (or other numerical value) calculated outside of IPA\n• Other lists where you have mainly IDs and but no differential expression data \nIn this IPA training\, you’ll learn how to:\n• Upload and perform a pathway analysis (also known as core analysis) on a list of genes\, proteins\, metabolites or other types of IDs\n• Open and investigate pathways and networks for understanding biological mechanisms\n• Compare between analyses to identify similarities and differences for applications such as biomarker discovery\n• Generate a custom network and contextualize it using public data
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/pathway-and-network-analysis-on-different-types-of-lists-with-qiagen-ipa/
LOCATION:Virtual - Americas - EST\, United States
CATEGORIES:Discovery,Webinar
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20230518T100000
DTEND;TZID=UTC:20230518T120000
DTSTAMP:20260504T030418
CREATED:20230329T122532Z
LAST-MODIFIED:20241024T182851Z
UID:10000626-1684404000-1684411200@staging.digitalinsights.supremeclients.com
SUMMARY:How to improve your existing pipeline for somatic mutation analysis\, interpretation and reporting: Part 2
DESCRIPTION:We are excited to bring thought leaders\, NGS experts\, lab directors\, variant scientists\, clinicians\, and oncologists under one virtual roof at our second annual Clinical Oncology Summit hosted on April 27 and May 18\, 2023. \nThe two-part\, content-rich event will feature invited lectures from lab directors and clinical geneticists\, thought-provoking discussions on the future of comprehensive genomic profiling\, and educational presentations on the latest databases\, software\, and services for somatic secondary and tertiary analysis. Designed to help clinical diagnostic labs understand how they can optimize their current pipelines for somatic NGS analysis\, interpretation and reporting\, the Clinical Oncology Summit is a must-attend event for labs who need to reduce turnaround time\, improve operational costs\, and scale for higher throughput. \nMeet the speakers and view the full agenda here.
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/how-to-improve-your-existing-pipeline-for-somatic-mutation-analysis-interpretation-and-reporting-part-2/
CATEGORIES:Clinical,Event
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20230523T130000
DTEND;TZID=UTC:20230523T143000
DTSTAMP:20260504T030418
CREATED:20230418T125027Z
LAST-MODIFIED:20241024T182856Z
UID:10000635-1684846800-1684852200@staging.digitalinsights.supremeclients.com
SUMMARY:IPA deeper dive: miRNA investigation using QIAGEN Ingenuity Pathway Analysis (IPA)
DESCRIPTION:In this 90-minute training session\, you will learn how to identify target mRNAs for your miRNAs of interest and associate them with pathways\, diseases\, biological functions\, tissues and cell types. \nWe’ll cover topics such as:\n- How to analyze miRNA-seq datasets alone\, or both miRNA and corresponding mRNA datasets together\n- How to use QIAGEN IPA without a dataset\, using miRNA IDs\n- Introduction to databases and curated content specific to miRNA\n- How to effectively apply various filters and functionalities to identify biomarkers\, key targets and novel biological mechanisms
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/ipa-deeper-dive-mirna-investigation-using-qiagen-ingenuity-pathway-analysis-ipa-2/
LOCATION:Virtual - Americas - EST\, United States
CATEGORIES:Discovery,Training
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20230525T130000
DTEND;TZID=UTC:20230525T143000
DTSTAMP:20260504T030418
CREATED:20230503T054433Z
LAST-MODIFIED:20241024T182859Z
UID:10000638-1685019600-1685025000@staging.digitalinsights.supremeclients.com
SUMMARY:Acceda rápidamente a amplios conocimientos para interpretar variantes somáticas con la HSMD
DESCRIPTION:Dentro de las aplicaciones oncológicas\, la capacidad de identificar alteraciones genéticas potencialmente accionables y explorar las vulnerabilidades moleculares del cáncer es cada vez más difícil. \n\nUna nueva base de datos desarrollada por QIAGEN\, la HSMD\, contiene más de 2 décadas de contenido curado por expertos y datos de la QIAGEN Knowledge Base con más de 300.000 casos de oncología del mundo real para proporcionar una comprensión profunda y precisa de la accionabilidad de pequeñas variantes\, como SNVs\, indels y frameshifts\, que han sido "clínicamente observadas" o consideradas por la literatura científica. \n\nEl 25 de mayo\, únase a nuestros expertos en un tour virtual a la nueva base de datos y una presentación de sus características\, capacidades y aplicaciones.
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/acceda-rapidamente-a-amplios-conocimientos-para-interpretar-variantes-somaticas-con-la-hsmd-may-25/
LOCATION:Virtual - Argentina\, Argentina
CATEGORIES:Clinical,Webinar
END:VEVENT
END:VCALENDAR